Oncosema

Oncosema is a purpose-driven company with a mission to dramatically improve the management of cancer patients by providing simple and non-invasive tools to assist oncologists in making the best informed decisions for each patient. It is a deeptech start-up that operates an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer.